Airway obstruction can arise from a variety of causes, including asthma, tumors, infections, foreign body aspiration, or trauma, and it often presents as a medical emergency requiring rapid assessment and intervention. The immediate priority is to restore patency and secure adequate airflow, sometimes necessitating intubation or tracheostomy in critical cases. In less acute scenarios, therapies are guided by the cause: bronchodilators and corticosteroids reduce inflammation in asthma, while antibiotics treat infection-related narrowing. For structural obstructions, minimally invasive procedures such as stent placement, laser therapy, or balloon dilation can provide rapid improvement in breathing. Advances in imaging and endoscopic technology allow more precise localization and treatment of lesions within the trachea and bronchi. Beyond acute measures, long-term management involves addressing underlying conditions, such as tumor resection in oncology or immunotherapy for inflammatory airway disease. Rehabilitation strategies, including breathing exercises and pulmonary physiotherapy, help restore confidence and respiratory function after interventions. Patient education is equally critical, particularly in recognizing early warning signs of obstruction to avoid emergency situations. By integrating pharmacological, procedural, and supportive care, airway obstruction relief highlights the importance of timely and personalized interventions that safeguard both survival and quality of life.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation